News & Events

Sixth issue of Health Update

16-Dec-2008

This issue highlights the new report Pharmaceutical Pricing Policies in a Global Market, as well as the WHO-OECD Dialogue on Migration and the Health Workforce, addressing pressures on long-term care systems, health and the environment, mental health and the workplace, and other key health-related projects throughout the OECD.

Current Developments/Activities on the Safety of Manufactured Nanomaterials/Nanotechnologies

11-Dec-2008

This document is a compilation of responses given during the Tour de Table by delegations that attended the 4th Meeting of the Working Party on Manufactured Nanomaterials held at OECD Headquarters in Paris, France on 11-13 June 2008. 

Are all jobs good for your health? The impact of work status and working conditions on mental health.

10-Dec-2008

Does the steep rise in disability benefit receipt for mental illness in many OECD countries reflect on overall increase in mental health problems in the working-age population? How does working and job stress affect mental health? Chapter 4 of the OECD Employment Outlook 2008  analyses issues related to work and health.

Pharmaceutical Pricing and Reimbursement Policies in Germany

29-Oct-2008

This paper (Health Working Paper No. 39) describes pharmaceutical pricing and reimbursement policies in Germany, considering them in the broader environment in which they operate, and assesses their impact on the achievement of a number of policy goals.

International Mobility of Health Professionals and Health Workforce Management in Canada: Myths and Realities

29-Oct-2008

This report (Health Working Paper No. 40) examines the role played by immigrant health workers in the Canadian health workforce as well as the interactions between migration policies and education and health workforce management policies.

Migration of Health Workers: The UK Perspective to 2006

29-Oct-2008

This paper (Health Working Paper No. 38) describes the migration of health workers to the U.K. until 2006 and potential future health expenditure.

Biotechnology, Innovation and Health

24-Oct-2008

The links between innovation, productivity, health and wealth are recognised by many countries and the need to encourage innovation is also apparent. Investing in and encouraging innovation is a priority for many jurisdictions as is the affordability, quality and sustainability of healthcare systems.

Nouvelles Lignes Directrices pour les Essais

23-Oct-2008

Les Nouvelles Lignes Directrices pour les Essais ont été adoptées le 3 Octobre 2008 et sont disponibles sur SourceOECD.

Section 2: Effets sur les systèmes biologiques
LD 226  
LD 228   

Section 3: Dégradation et accumulation
LD 314   
LD 315  
LD 316

Section 5: Autres Lignes directrices
LD 508

LD mises à jour pour les essais:
Section 2: Effets sur les systèmes biologiques
LD 211  

Section 4: Effets sur la santé
LD 407  

LD corrigée pour les essais:
Section 4: Effets sur la santé
LD 425  

Greater international cooperation needed to address looming shortages of doctors and nurses, says OECD

22-Oct-2008

OECD countries should adopt a comprehensive approach to the looming shortage of health workers, reinforce international cooperation and better monitor health workforce policies and international migration of doctors and nurses, according to a new OECD report.